Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients

Journal of Clinical Lipidology

Volumn 4, Issue 2, 2010, Pages 126-132

  Foody, JoAnne M ^a   Sajjan, Shiva G ^b   Hu, X Henry ^b   Ramey, Dena R ^b   Neff, David R ^b   Tershakovec, Andrew M ^b   Tomassini, Joanne E ^b   Wentworth, Chuck ^b   Tunceli, Kaan ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Atherosclerotic vascular disease; Coronary heart disease; Goal attainment; Lipid lowering therapy; Low density lipoprotein cholesterol

Indexed keywords

ATORVASTATIN; CLOFIBRATE; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREND STUDY;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; CHOLESTEROL, LDL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 77949810266     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.01.007     Document Type: Article

References (16)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 105 (2002) 3143-3421
2. Smith Jr. S.C., Allen J., Blair S.N., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
3. Ohsfeldt R.L., Gandhi S.K., Fox K.M., and McKenney J.M. Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications. Value Health 11 (2008) 1061-1069
4. Atar D., Carmena R., Clemmensen P., et al. Clinical review: impact of statin substitution policies on patient outcomes. Ann Med 41 (2009) 242-256
5. Aronow H., Hess G., Hill J., Kuznik A., and Liu L. Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol. Am J Ther (2009 Sep 15) [epub ahead of print] PMID: 19770794
6. Steinberg B.A., Bhatt D.L., Mehta S., et al. Diabetes and metabolism-nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J 156 (2008) 719-727
7. Catapano A.L. Perspectives on low-density lipoprotein cholesterol goal achievement. Curr Med Res Opin 25 (2009) 431-447
8. Waters D.D., Brotons C., Chiang C.W., et al. Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation 120 (2009) 28-34
9. Griend J.P.V., and Saseen J.J. Low-density lipoprotein cholesterol goal attainment in high-risk family medicine patients. J Clin Lipid 3 (2009) 195-200
10. Cullen M.W., Stein J.H., Gangnon R., McBride P.E., and Keevil J.G. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002. Am Heart J 156 (2008) 284-291
11. Devine J., Linton A., Mistry H., Mapier J., Trice S., and Bacon T. Increase in lipid-lowering treatment rates among TRICARE beneficiaries: A population-based study. Pharmacoepidemiol Drug Safety 18 (2009) 891-899
12. Nag S.S., Pearson T.A., Ma L., et al. Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. Am J Cardiol 95 (2005) 862-864
13. Assmann G., Benecke H., Neiss A., Cullen P., Schulte H., and Bestehorn K. Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events including Physicians' Experience and Evaluation). Eur J Cardiovasc Prev Rehabil 13 (2006) 776-783
14. Ghandehari H., Kamal-Bahl S., and Wong N.D. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004. Am Heart J 156 (2008) 112-119
15. Davidson M.H., Maki K.C., Pearson T.A., et al. Results of the National Cholesterol Education Program (NCEP) Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol 96 (2005) 556-563
16. Keevil J.G., Cullen M.W., Gangnon R., McBride P.E., and Stein J.H. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia-Data from National Health and Nutrition Examination Survey 1999 to 2002. Circulation 115 (2007) 1363-1370